alexa Opioid Addiction Treatment Using Buprenorphine-Naloxone In A Community-Based Internal Medicine Practice.
Pharmaceutical Sciences

Pharmaceutical Sciences

Journal of Bioequivalence & Bioavailability

Author(s): Van Doren BA, FoulksRodriguez KA, Yarborough W

Abstract Share this page

Abstract BACKGROUND: Opioid dependency currently affects over 2.5 million patients in the United States and is increasing in incidence. Office-based opioid therapy with buprenorphine-naloxone provides greater patient access to treatment and has significantly improved therapeutic outcomes. METHODS: We conducted a study of 100 consecutive patients treated for opioid dependence with buprenorphine-naloxone in a single provider's community-based internal medicine practice. The primary outcome measures were retention in therapy, wellness, and abstinence from ongoing drug use. Data were obtained from frequent physical examinations, self-report data, and periodic urine drug screening. RESULTS: The retention rate in therapy was 75\%. A multidimensional evaluation of wellness improved in 75\% of the patients. Eighty-five percent reported no opiate relapse during therapy. CONCLUSION: Office-based opioid therapy with buprenorphine-naloxone has provided greater access to therapy with improved therapeutic outcomes. Our findings support the mounting literature that more patients should be offered office-based opioid therapy for opioid dependency.
This article was published in J Okla State Med Assoc and referenced in Journal of Bioequivalence & Bioavailability

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version